← Eichor
Study identifier: NCT07337538 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region.

Condition: Implant Stability  ·  Sponsor: University of Baghdad

PhaseNA
Planned participants20
Who can joinAll sexes, 15 Years to 38 Years
Healthy volunteersYes

About this study

The goal of this clinical trials is to compare two diameters, 1.6 and 2 mm, of mini implants both are 12 mm length placed in the infrazygomatic crest region. The main questions it aims to answer are: which diameter is more suitable for IZC region 1.6 or 2mm in terms of primary stability, secondary stability, pain perception and failure rate. 20 participant will receive 40 mini implant bilaterally (20 in one side of 1.6mm, the other side 20 of 2mm). participants will be asked to record visual analog scale (VAS) for 3 nights monitored monthly by the investigator.

This description comes directly from the study's public registry record.

Talk to the study team

Ali J. Al Ameri, BDS.  ·  +9647775039229  ·  Ali.Fahd2403@codental.uobaghdad.edu.iq

Mehdi A. Alrubayee, PHD.  ·  +9647703909151  ·  mehdi.a.151@codental.uobaghdad.edu.iq

Always discuss trial participation with your own doctor first.

Locations (2)

Saydiya dental clinicBaghdad, Baghdad Governorate, IraqNot Yet Recruiting
Baghdad universityBaghdad, Baghdad Governorate, IraqRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07337538